2010
DOI: 10.4161/bbug.1.5.12086
|View full text |Cite
|
Sign up to set email alerts
|

Lactococcus lactisas an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
24
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(26 citation statements)
references
References 86 publications
(113 reference statements)
2
24
0
Order By: Relevance
“…Many LAB species are also used as probiotics for human and animal consumption (Gilliland, 1989) and have generally regarded as safe (GRAS) Food and Drug Administration (FDA) status. In addition, most LAB are quite acid resistant and certain strains are able to effectively survive passage through the gastrointestinal (GI) tract, making LAB attractive potential delivery vehicles for recombinant protein vaccines (Medina et al, 2010). However, not all LAB species have a positive impact on food production or human health.…”
Section: Introductionmentioning
confidence: 99%
“…Many LAB species are also used as probiotics for human and animal consumption (Gilliland, 1989) and have generally regarded as safe (GRAS) Food and Drug Administration (FDA) status. In addition, most LAB are quite acid resistant and certain strains are able to effectively survive passage through the gastrointestinal (GI) tract, making LAB attractive potential delivery vehicles for recombinant protein vaccines (Medina et al, 2010). However, not all LAB species have a positive impact on food production or human health.…”
Section: Introductionmentioning
confidence: 99%
“…However, mucosal vaccination has several benefits over the parenteral way: it is easy to administer, it can be administered through the same route of entry as pathogens, it makes self-administration possible and is able to induce the systemic and mucosal immune response. The nasal route is undoubtedly the better way to provide immunization against pathogens that enter the body through the respiratory tract and generally an appropriate immune response in the mucosal and systemic compartments is induced against specific antigens [5,20,21]. However, in contrast to parenteral immunization, mucosal immunizations require potent adjuvants to enhance immunogenicity.…”
Section: Discussionmentioning
confidence: 99%
“…Lactic acid bacteria have been used as a live oral vaccine expression system for their safety, weak immunogenicity and adjuvant properties (Bermú dez-Humarán, 2009;Hanniffy et al, 2007;Liu et al, 2009;Medina et al, 2010;Wei et al, 2010). As a specific lactic acid bacterium in the human intestinal tract, BI is an advantageous vehicle for mucosal vaccination purposes because it is considered safer than other live vaccine carriers, which have pathogenic variants (e.g.…”
Section: Discussionmentioning
confidence: 99%